| Literature DB >> 21660111 |
Vijay K Bharti1, R S Srivastava, P Subramaian, D Warren Spence, S R Pandi-Perumal, Gregory M Brown.
Abstract
The cerebral epiphysis (pineal gland) secrets melatonin and number of other proteins and peptides. It was thus hypothesized that antioxidant properties of epiphyseal proteins and melatonin could potentially benefit from exogenous therapies. In view of the therapeutic potential of these proteins, the present experiment was conducted to investigate the effect of buffalo epiphyseal proteins (BEP, at 100 μg/kg BW, i.p.) and melatonin (MEL, at 10 mg/kg BW, i.p) on changes in hepatic and renal antioxidant enzymes of adult female Wistar rats. Buffalo epiphyseal proteins significantly (P < .05) increased hepatic lipid peroxidation (LPO), superoxide dismutase (SOD), glutathione reductase (GR), glutathione peroxidase (GPx), reduced glutathione (GSH), and renal LPO, catalase (CAT), GR, GSH, GPx levels as compared to control animals. Similarly, MEL treatment significantly (P < .05) up-regulated hepatic SOD and GPx activity, whereas CAT, GR, GPx, and GSH levels in renal tissues were increased while SOD and LPO remained unaffected. Buffalo epiphyseal protein treatment produced greater effects on hepatic GPx and renal CAT and GSH levels than did MEL. These findings support the conclusion that buffalo epiphyseal proteins and melatonin activate a number of antioxidant mechanisms in hepatic and renal tissues.Entities:
Year: 2011 PMID: 21660111 PMCID: PMC3106360 DOI: 10.4061/2011/142896
Source DB: PubMed Journal: Int J Nephrol
Distribution of experimental rats to different treatments.
| Groups ( | Treatments | Dose | Route of administration |
|---|---|---|---|
| Control | Drinking water + Normal saline | Oral Intraperitoneal | |
| BEP | Buffalo epiphyseal proteins (BEPs) | 100 | Intraperitoneal |
| MEL | Melatonin (MEL) | 10 mg/kg BW | Intraperitoneal |
Effects of different treatments on lipid peroxidation (LPO), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR), and reduced glutathione (GSH) in liver of female rats.
| Group | Parameters | |||||
|---|---|---|---|---|---|---|
| LPO (nM MDA/mL) | CAT (nM/min/mg protein) | SOD (U) | GR (nM/min/mg protein) | GPx (nM/min/mg protein) | GSH ( | |
| Control | 4.61a ± 0.11 | 291.03a ± 14.93 | 6.15a ± 0.37 | 145.85a ± 7.33 | 25.67a ± 1.87 | 3.30a ± 0.06 |
| BEP | 5.78b ± 0.21 | 293.45a ± 9.20 | 7.94b ± 0.24 | 189.17b ± 5.79 | 37.44c ± 1.70 | 4.49b ± 0.08 |
| MEL | 4.89a ± 0.13 | 300.40a ± 11.68 | 7.60b ± 0.33 | 139.32a ± 13.12 | 30.28b ± 1.03 | 3.50a ± 0.15 |
Values (n = 6; Means ± S.E) in the same column bearing no superscript (a, b, c) common vary significantly (P < .05).
Effects of different treatments on lipid peroxidation (LPO), catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR), and reduced glutathione (GSH) in kidney of female rats.
| Group | Parameters | |||||
|---|---|---|---|---|---|---|
| LPO (nM MDA/mL) | CAT (nM/min/mg protein) | SOD (U) | GR (nM/min/mg protein) | GPx (nM/min/mg protein) | GSH ( | |
| Control | 4.99a ± 0.13 | 251.70a ± 4.58 | 5.98a ± 0.17 | 126.64a ± 8.47 | 20.13a ± 1.11 | 3.50a ± 0.06 |
| BEP | 5.80b ± 0.11 | 327.49c ± 18.14 | 5.46a ± 0.31 | 168.14b ± 6.20 | 36.99b ± 3.69 | 5.91c ± 0.15 |
| MEL | 4.95a ± 0.12 | 284.10b ± 2.79 | 6.12a ± 0.34 | 152.82b ± 10.54 | 32.48b ± 1.92 | 4.19b ± 0.113 |
Values (n = 6; Means ± S.E) in the same column bearing no superscript (a, b, c) common vary significantly (P < .05).